Ark Diagnostics Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Ark Diagnostics Inc.
With the FDA bottleneck for new anti-infectives showing signs of improvement, the next concern is whether providers will pay high premiums for new anti-infectives and the related challenge of finding the right patients to make high-cost treatments make sense.
A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing